Felix Geissler
Keine laufenden Positionen mehr
Karriereverlauf von Felix Geissler
Ehemalige bekannte Positionen von Felix Geissler
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CURIS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 03.01.2022 | 01.01.2023 |
| Sanofi Corp. | Corporate Officer/Principal | - | - |
Lumicell, Inc.
 Lumicell, Inc. Electronic Equipment/InstrumentsElectronic Technology Lumicell, Inc. develops and markets image-guided cancer surgery solutions. It offers Lumicell System, designed to enable surgeons to see residual cancer cells in the cavity walls in real-time during surgery. The company was founded by Linda G. Griffith, David G. Kirsch, Jorge M. Ferrer, Ralph Weissleder, W. David Lee, Andrey J. Zarur, and Moungi G. Bawendi in 2008 and is headquartered in Wellesley, MA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Felix Geissler
| Eberhard Karls Universität Tübingen | Doctorate Degree |
| University of Innsbruck | Doctorate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Deutschland | 3 |
| Österreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 3 |
| Corporate Officer/Principal | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CURIS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Lumicell, Inc.
Lumicell, Inc. Electronic Equipment/InstrumentsElectronic Technology Lumicell, Inc. develops and markets image-guided cancer surgery solutions. It offers Lumicell System, designed to enable surgeons to see residual cancer cells in the cavity walls in real-time during surgery. The company was founded by Linda G. Griffith, David G. Kirsch, Jorge M. Ferrer, Ralph Weissleder, W. David Lee, Andrey J. Zarur, and Moungi G. Bawendi in 2008 and is headquartered in Wellesley, MA. | Electronic Technology |
| Sanofi Corp. |
- Börse
- Insiders
- Felix Geissler
- Erfahrung
